Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "US Prostate Cancer Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
US Prostate Cancer Market provides comprehensive insights into Prostate Cancer pipeline products, Prostate Cancer epidemiology, Prostate Cancer market valuations and forecast, Prostate Cancer drugs sales and competitive landscape in the US.
The research is classified into seven sections- Prostate Cancer treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Benefits of this Research
Key Topics Covered
1) Prostate Cancer Treatments
2) Prostate Cancer Pipeline
3) US Prostate Cancer Epidemiology
4) Marketed Drugs for Prostate Cancer in US
5) US Prostate Cancer Market Size and Forecast
6) US Prostate Cancer Products Sales and Forecast
7) US Prostate Cancer Market Competitive Landscape
List of Tables
1. Prostate Cancer Phase 3 Clinical Trials, 2019
2. Prostate Cancer Phase 2 Clinical Trials, 2019
3. Prostate Cancer Phase 1 Clinical Trials, 2019
4. Prostate Cancer Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Prostate Cancer, US, 2018
6. Prostate Cancer Market Size and Forecast ($), US, 2014 - 2024
7. Prostate Cancer Product Sales ($), US, 2014 - 2024
List of Figures
1. Prostate Cancer Epidemiology, US, 2014 - 2024
2. Prostate Cancer Market Size and Forecast ($), US, 2014 - 2024
3. Prostate Cancer Products Market Share (%), US, 2018
For more information about this report visit https://www.researchandmarkets.com/r/e7uk8l
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Prostate Cancer Drugs